News
All are invited to attend the NCI Technology Transfer Center’s upcoming technology opportunity webinar entitled, “Proteolysis Targeting Chimeras (PROTACs) Targeting PIM Kinase for the Treatment of Cancer,” on April 24, from 11:00 a.m. to 12:00 p.m. The inventor, S enior Investigator, Dr. John
Register to attend a free NIH webinar featuring a licensing opportunity for a first-of-its-kind male contraceptive hormonal gel, Nestorone®/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self
The National Institutes of Health (NIH) engaged RTI International, a nonprofit research institute, to develop new methods for characterizing and measuring the impact of technologies developed by NIH’s Intramural Research Program. The RTI team created models to illustrate how technologies licensed
Are you interested in achieving commercial success with NIH as a strategic partner? Michael Salgaller of the National Cancer Institute (NCI) is leading a workshop at the MedInvest Oncology Investor Conference on how to partner with NIH to bring one of over 2,000 available inventions to market. This